The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors

Advances in Protein Chemistry

Volumn 68, Issue , 2004, Pages 147-169

  Kossiakoff, Anthony A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PLACENTA LACTOGEN; PROLACTIN; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; PROLACTIN RECEPTOR;

BIOLOGICAL ACTIVITY; ENDOCRINE FUNCTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE STRUCTURE; PRIORITY JOURNAL; REVIEW; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AVES; MAMMALIA; PISCES; PRIMATES;

ANIMALS; BINDING SITES; HUMAN GROWTH HORMONE; HUMANS; MODELS, MOLECULAR; PROLACTIN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PROLACTIN; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 16544375435     PISSN: 00653233     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3233(04)68005-3     Document Type: Article

References (57)

1. Argetsinger, L., Campbell, G., Yang, X., Witthuhn, B., Silvennoinen, O., IhIe, J., and Carter-Su, C. (1993). Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
2. Atwell, S., Ultsch, M. H., De Vos, A. M., and Wells, J. A. (1997). Structural plasticity in a remodeled protein-protein interface. Science 278, 1125-1128.
3. Banner, D. W., D'Arcy, A. D., Chene, C., Winkler, F. K., Guha, A., Konigsberg, W. H., Nermerson, Y., and Kirchhofer, D. (1996). The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380, 41-46.
4. Bazan, J. F. (1990). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934-6938.
5. Bernat, B., Pal, G., Sun, M., and Kossiakoff, A. A. (2003). Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc. Natl. Acad. Sci. USA 100(3), 952-957.
6. Clackson, T., Ultsch, M. H., Wells, J. A., and De Vos, A. M. (1998). Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277(5), 1111-1128.
7. Clackson, T., and Wells, J. A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267(5196), 383-386.
8. Cosman, D., Lyman, S. D., Idzerda, R. L., Reckmann, M. P., Park, L. S., Goodwin, R. G., and March, C. J. (1990). A new cytokine receptor superfamily. Trends Biochem. Sci. 15, 265-270.
9. Cunningham, B. C., Bass, S., Fuh, G., and Wells, J. A. (1990a). Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250, 1709-1712.
10. Cunningham, B. C., Henner, D. J., and Wells, J. A. (1990b). Engineering human prolactin to bind to the human growth hormone receptor. Science 247(4949 Pt 1), 1461-1465.
11. Cunningham, B. C., and Wells, J. A. (1989). High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244, 1081-1085.
12. Cunningham, B. C., and Wells, J. A. (1991). Rational design of receptor-specific variants of human growth hormone. Proc. Natl. Acad. Sci. USA 88, 3407-3411.
13. Cunningham, B. C., and Wells, J. A. (1993). Comparison of a structural and a functional epitope. J. Mol. Biol. 234, 554-563.
14. De Vos, A. M., and Kossiakoff, A. A. (1992). Receptor action and interaction. Curr. Opin. Struct. Biol. 2, 852-858.
15. De Vos, A. M., Ultsch, M., and Kossiakoff, A. A. (1992). Human Growth Hormone and Extracellular Domain of its Receptor: Crystal Structure of the Complex. Science 255, 306-312.
16. DeVlaming, V. (1979). Actions of prolactin among the vertebrates. In "Hormones and Evolution" (E. J. W. Barrington, Ed.), pp. 561-642. Academic Press, New York.
17. Duquesnoy, P., Sobrier, M. L., Duriez, B., Dastot, F., Buchanan, C. R., Savage, M. O., Preece, M. A., Craescu, C. T., Blouquit, Y., and Goossens, M. et al. (1994). A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13(6), 1386-1395.
18. Elkins, P. A., Christinger, H. W., Sandowski, Y., Sakal, E., Gertler, A., De Vos, A. M., and Kossiakoff, A. A. (2000). Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor. Nat. Struct. Biol. 7(9), 808-815.
19. Fuh, G., Mulkerrin, M. G., Bass, S., McFarland, N., Brochier, M., Bourell, J. H., Light, D. R., and Wells, J. A. (1990). The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. J Biol. Chem. 265(6), 3111-3115.
20. Gerder, A., Grosclaude, J., Strasburger, C. J., Nir, S., and Djiane, J. (1996). Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol. Chem. 271(40), 24482-24491.
21. Coffin, V., Shiverick, K. T., Kelly, P. A., and Martial, J. A. (1996). Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocrine Reviews 17, 385-410.
22. Hensley, P., Doyle, M. L., Myszka, D. G., Woody, R. W., Brigham-Burke, M. R., Erickson-Miller, C. L., Griffin, C. A., Jones, C. S., McNulty, D. E., O'Brien, S. P., Amegadzie, B. Y., MacKenzie, L., Ryan, M. D., and Young, P. R. (2000). Evaluating energetics of erythropoietin ligand binding to homodimerized receptor extracellular domains. Methods Enzymol. 323, 177-207.
23. Herman, A., Helman, D., Livnah, O., and Gertler, A. (1999). Ruminant placental lactogens act as antagonists to homologous growth hormone receptors and as agonists to human or rabbit growth hormone receptors. J. Biol. Chem. 274, 7631-7639.
24. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., and Silvennoinen, O. (1994). Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19, 222-227.
25. Kelly, P. A., Djiane, J., Banville, D., Ali, S., Edery, M., and Rozakis, M. (1991). The growth hormone/prolactin receptor gene family. Oxford Surveys On Eukaryotic Genes 7, 29-50.
26. Kossiakoff, A. A., and De Vos, A. M. (1998). Structural basis for cytokine hormone-receptor recognition and receptor activation. Advances In Protein Chemistry 52, 67-108.
27. Kossiakoff, A. A., Somers, W., Ultsch, M., Andow, K., Muller, Y., and De Vos, A. M. (1994). Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Science 3, 1697-1705.
28. Lebrun, J. J., Ali, S., Sofer, L., Ullrich, A., and Kelly, P. A. (1994). Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269, 14021-14026.
29. Liparoto, S. F., and Ciardelli, T. L. (1999). Biosensor analysis of the interleukin-2 receptor complex. J. Mol. Recognit. 12(5), 316-321.
30. Livnah, O., Johnson, D. L., Stura, E. A., Farrell, F. X., Barbone, F. P., You, Y., Liu, K. D., Goldsmith, M. A., He, W., Krause, C. D., Pestka, S., Jolliffe, L. K., and Wilson, I. A. (1998). An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat. Struct. Biol. 5(11), 993-1004.
31. Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., and Wilson, I. A. (1996). Functional mimicry of a protein hormone by a peptide agonist: The EPO receptor complex at 2.8 Å. Science 273(5274), 464-471.
32. Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999). Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283 (5404), 987-990.
33. Lowman, H. B., Bass, S. H., Simpson, N., and Wells, J. A. (1991a). Selecting high-affinity binding proteins by monovalent phage display. Biochemistry 30, 10832-10838.
34. Lowman, H. B., Cunningham, B. C., and Wells, J. A. (1991b). Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J. Biol. Chem. 266, 10982-10988.
35. Lowman, H. B., and Wells, J. A. (1993). Affinity maturation of human growth hormone: Monovalent phage display. J. Mol. Biol. 234, 564-578.
36. Nice, E., Layton, J., Fabri, L., Hellman, U., Engstrom, A., Persson, B., and Burgess, A. W. (1993). Mapping of the antibody- and receptor-binding domains of granulocyte colony-stimulating factor using an optical biosensor. Comparison with enzyme-linked immunosorbent assay competition studies. J. Chromatogr. 646(1), 159-168.
37. Nicoll, C. S., Mayer, G. L., and Russel, S. M. (1986). Structural features of prolactins and growth hormones that can be related to their biological properties. Endocrine Rev. 7, 169-203.
38. Pal, G., Kossiakoff, A. A., and Sidhu, S. S. (2003). The functional binding epitope of a high affinity variant of human growth hormone mapped by shotgun alanine-scanning mutagenesis: Insights into the mechanisms responsible for improved affinity. J. Mol. Biol. 332(1), 195-204.
39. Pearce, K. H., Jr., Cunningham, B. C., Fuh, G., Teeri, T., and Wells, J. A. (1999). Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. Biochemistry 38(1), 81-89.
40. Pearce, K. H. J., UItsch, M. H., Kelley, R. F., De Vos, A. M., and Wells, J. A. (1996). Structural and mutational analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry 35(32), 10300-10307.
41. Randal, M., and Kossiakoff, A. A. (2001). The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex. Structure (Camb) 9(2), 155-163.
42. Remy, I., Wilson, I. A., and Michnick, S. W. (1999). Erythropoietin receptor activation by ligand-induced conformation change science. Science 283, 990-993.
43. Schiffer, C., Ultsch, M., Walsh, S., Somers, W., De Vos, A. M., and Kossiakoff, A. (2002). Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: Evidence for strong structural coupling between receptor binding sites. J. Mol. Biol. 316(2), 277-289.
44. Shen, B. J., Hage, T., and Sebald, W. (1996). Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. Eur. J. Biochem. 240(1), 252-261.
45. Sinha, Y. N. (1995). Structural Variants of Prolactin: Occurrence and Physiological Significance. Endocrine Reviews 16(3), 354-369.
46. Smith, J. L., Corfield, P. W. R., Hendrickson, W. A., and Low, B. W. (1988). Refinement at 1.4 A resolution of a model of erabutoxin b: Treatment of ordered solvent and discrete disorder. Acts. Cryslallogr. Sect. A 44, 357-368.
47. Somers, W., Ultsch, M., De Vos, A. M., and Kossiakoff, A. A. (1994). The X-ray structure of the growth hormone-prolactin receptor complex. Nature 372, 478-481.
48. Sprang, S. R., and Bazan, J. F. (1993). Cytokine structural taxonomy and mechanisms of receptor engagement. Curr. Opin. Struct. Biol . 3, 815-827.
49. Syed, R. S., Reid, S. W., Li, C., Cheetham, J. C., Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J., Finer-Moore, J., Elliott, S., Sitney, K., Katz, B. A., Matthews, D. J., Wendoloski, J. J., Egrie, J., and Stroud, R. M. (1998). Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395(6701), 511-516.
50. Ultsch, M., Somers, W., Kossiakoff, A. A., and De Vos, A. M. (1994). The crystal structure of affinity-matured human growth hormone at 2 A resolution. J. Mol. Biol. 236, 286-299.
51. Walsh, S. T., Jevitts, L. M., Sylvester, J. E., and Kossiakoff, A. A. (2003). Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization. Protein Sci. 12(9), 1960-1970.
52. Walter, M. R., Windsor, W. T., Nagabhushan, T. L., Lundell, D. J., Lunn, C. A., Zauodny, P. J., and Narula, S. K. (1995). Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 376, 230-235.
53. Wang, Y., Shen, B. J., and Sebald, W. (1997). A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. Proc. Natl. Acad. Sci. USA 94(5), 1657-1662.
54. Wells, J. A. (1991). Systematic mutational analyses of protein-protein interfaces. Methods Enzymol. 202, 390-411.
55. Wells, J. A., and De Vos, A. M. (1996). Hematopoietic receptor complexes. Annu. Rev. Biochem. 65, 609-634.
56. Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C., Wells, J. A., and De Vos, A. M. (1997). Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the FLt-1 receptor. Cell 5, 695-704.
57. Wilson, I. A., and Jolliffe, L. K. (1999). The structure, organization, activation and plasticity of the erythropoietin receptor. Curr. Opin. Struct. Biol. 9(6), 696-704.